Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.

Documenti analoghi

• Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation.
  di: Macintyre, E A, et al.
  Pubblicazione: (1987)
• Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
  di: Vaughan Hudson, B., et al.
  Pubblicazione: (1994)
• Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases.
  di: Morton, J. E., et al.
  Pubblicazione: (1993)
• British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
  di: Hancock, B. W., et al.
  Pubblicazione: (1991)
• Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
  di: Devereux, S, et al.
  Pubblicazione: (1990)